Veklury remdesivir Injection 100 mg Per Vial by Gilead Sciences (RX)

FDA-Approved Remdesivir Injectable Antiviral – Trusted Hospital Therapy for COVID-19 and Serious Viral Infections

Empower your hospital, clinic, or pharmacy with Gilead Sciences’ Veklury Remdesivir Injection 100 mg/vial—one of the world’s most clinically recognized and recommended treatments for hospitalized COVID-19 patients. This prescription antiviral, backed by rigorous clinical trials and global use, has become the standard of care for severe coronavirus and viral pneumonia cases, trusted by infectious disease specialists, intensive care units, and emergency departments.

Product Highlights & Clinical Benefits

• Veklury (Remdesivir) Injection 100 mg

  • Single-dose, preservative-free lyophilized powder for solution—sterile and pyrogen-free
  • Manufactured by Gilead Sciences, a global leader in antiviral and infectious disease therapy

• FDA-Approved Antiviral Medication

  • Approved for use in adults and pediatric patients (12 years and older, weighing at least 40 kg) requiring hospitalization for severe COVID-19

• Powerful Antiviral Activity

  • Inhibits RNA-dependent RNA polymerase, blocking SARS-CoV-2 viral replication
  • Demonstrated to reduce time to recovery and improve clinical outcomes in hospitalized patients

• Hospital and ICU Ready

  • Used in intensive care, infectious disease, pulmonary, and emergency departments nationwide
  • Available in convenient 100 mg per vial format for precise dosing and compounding IV infusions

• Pharmacy, Hospital, and Clinical Supply

  • A vital resource for pharmacy stock, emergency preparedness, pandemic response, and outbreak management

Top Clinical Uses

• Treatment of COVID-19: First-line prescription therapy for hospitalized coronavirus disease, severe COVID-19 pneumonia, and SARS-CoV-2 infections
• Antiviral for Viral Pneumonia: Inhibits coronavirus replication and reduces respiratory complications in eligible patients
• Infectious Disease Management: Used in protocols by infectious disease doctors for serious, acute viral infections in adult and pediatric populations
• ICU and Critical Care Therapy: Trusted by hospitals and emergency rooms for rapid intervention and improved survival rates in severe cases
• Hospital Pharmacy Supply: Ensures preparedness during COVID surges, pandemics, and emergency situations

Why Choose Veklury Remdesivir by Gilead Sciences?

• Proven Clinical Efficacy: Supported by large-scale clinical trials (ACTT-1, PINETREE) and endorsed by infectious disease and critical care guidelines
• Trusted Brand: Manufactured by Gilead Sciences—pioneers in antiviral, HIV, and hepatitis therapies
• Sterile, Ready-to-Use Vials: Preservative-free, pyrogen-free, and suitable for rapid IV preparation in hospital settings
• Comprehensive Documentation: Full regulatory compliance, FDA approval, and global health authority recognition

Order Veklury Remdesivir Injection 100 mg by Gilead Sciences now—empowering your hospital or clinic to provide the gold-standard in antiviral therapy, COVID-19 treatment, and critical care support during outbreaks and infectious disease emergencies.

Gilead Sciences: Leading the way in advanced antiviral medicines for hospital, emergency, and intensive care use worldwide.